Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy alone in pre- and postmenopausal women with breast cancer.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/cognition-worse-combo-therapy-than-endo-alone-patients-2026a1000023?src=rss
Author :
Publish date : 2026-01-02 10:43:00
Copyright for syndicated content belongs to the linked Source.
